What is MatTek?
MatTek Life Sciences specializes in advanced tissue engineering, developing human cell-based tissue models and cultureware for diverse research applications. Their product portfolio supports critical testing in areas such as dermal, ocular, oral, intestinal, and respiratory research. The company provides a comprehensive suite of offerings, including various tissue models, specialized cultureware, primary cells, and toxicology services, primarily catering to clients within the pharmaceutical and biotechnology industries. Since its inception in 1985, MatTek has consistently applied its deep expertise to deliver predictive human biology solutions, positioning itself as a leader in the field.
How much funding has MatTek raised?
MatTek has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in MatTek
PPP
Public-Private Partnership
What's next for MatTek?
The substantial enterprise-level capital infusion signifies MatTek's maturity and strategic importance in the life sciences market. This significant backing is expected to fuel further innovation in their tissue engineering capabilities and expand their service offerings. The company is likely to leverage this investment to enhance its research and development efforts, potentially exploring new applications for its human cell-based models or scaling its toxicology services to meet growing industry demand for more predictive and ethical testing methods. MatTek's continued focus on providing advanced in vitro solutions positions it for sustained growth and influence in the global biotechnology landscape.
See full MatTek company page
